Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma

计划入组 90 人 · 首次发布于 2022 年 2 月 23 日

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

计划入组 33 人 · 首次发布于 2011 年 12 月 7 日

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

计划入组 66 人 · 首次发布于 2015 年 3 月 11 日

Orelabrutinib

C₂₆H₂₅N₃O₃ · Rx

Adebrelimab

Rx

panitumumab(Vectibix)

Rx

Toripalimab, Lenvatinib, and GEMOX Combination Shows Promise in Advanced Intrahepatic Cholangiocarcinoma

Glofitamab-GemOx Shows Survival Benefit in Phase 3 STARGLO Trial for R/R DLBCL, But FDA Advisory Committee Questions US Applicability

Atezolizumab, Bevacizumab, and GEMOX Combination Shows Promise in Advanced Biliary Tract Cancer